The Gosset platform
Accessible pharma intelligence
Search connected pharma data, investigate the evidence and build research reports. A single source of truth for your next analysis.
Gosset Platform
- Intuitivedashboards
- Agenticreports
- Comprehensivemonitoring
Intuitive dashboards
Access Gosset's comprehensive data using simple, intuitive dashboards. Drill down with nuanced filtering powered by proprietary ontologies and extremely high-quality curation. Links to primary sources are included with every data point so you can quickly access the underlying evidence.

Agentic reports
Our agents reason over Gosset's best-in-class data, pull in primary sources, and assemble a finished report, delivered as a slide deck, written document, spreadsheet or interactive report. Each report cites its sources, so every claim can be traced back to the evidence behind it.
Examples
- Interactive report
HCXT-2001: oral IL-23R inhibition
Data as of 23 Oct 2026An asset deep dive into the mechanism, early clinical evidence, competitive landscape and Gilead’s announced program acquisition.
ExampleHCXT-2001
Open report - Interactive report
Search & evaluation
Generated 30 Sep 2026 (data snapshot time not recorded)Comprehensive screening of every asset being developed for your disease, along with the context to understand their potential.
ExampleHuntington's disease
Open report - Google Sheets
Head-to-head results
Side-by-side comparison of trial outcomes for a drug class or indication. Covers safety, efficacy, patient population, and trial design.
ExampleIL-13 vs IL-4Rα biologics in atopic dermatitis (EASI-75, IGA 0/1)
Open spreadsheet - Slide deck
Asset due diligence
Full due-diligence assessment of a drug asset: thesis, evidence, competitive landscape, IP, pricing, and risks.
ExampleFrexalimab for relapsing multiple sclerosis
View deck - Written report
Standard of care
The current standard of care for a given disease, grounded in drug labels and treatment guidelines.
ExampleGeneralized myasthenia gravis
Read report - Google Sheets
Competitive landscaping
Every drug targeting a given target or modality, with detailed development status.
ExampleAnti-TL1A antibodies in inflammatory bowel disease
Open spreadsheet - Slide deck
Disease brief
A business development brief for a disease: unmet need, epidemiology, pipeline & competition, deals, and risk.
ExampleIgA nephropathy
View deck
Comprehensive monitoring
AI Monitor watches the landscape for you. Describe what to follow, whether an indication, a target, a modality or any combination, and Gosset pulls together the last twelve months of activity, then keeps watching.
New trials, results, approvals, deals and news arrive as a daily or weekly digest, and critical events are emailed the moment they land.
Open AI Monitor